Latest News about NKTR
Recent news which mentions NKTR
From Benzinga
Why Nektar Therapeutics Shares Are Falling Today
March 14, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
SolarEdge, FactSet and Signature Bank to join S&P 500 index
December 03, 2021
From MarketWatch
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
November 29, 2021
From MarketWatch
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021
November 08, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
92 Biggest Movers From Friday
November 08, 2021
From Benzinga
64 Stocks Moving In Friday's Mid-Day Session
November 05, 2021
From Benzinga
Nektar Therapeutics (NKTR) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
NKTR
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 18, 2021
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
September 21, 2021
From Benzinga
How Bad Are Nektar Therapeutics's Earnings? | Return on Capital Employed
September 02, 2021
Tickers
NKTR
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 20, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.